Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

被引：0
|
作者：
Ohoud Aljuhani
Khalid Al Sulaiman
Adel Alshabasy
Khalid Eljaaly
Abdulrahman I. Al Shaya
Haytham Noureldeen
Mohammed Aboudeif
Bodoor Al Dosari
Amina Alkhalaf
Ghazwa B. Korayem
Muneera M. Aleissa
Hisham A. Badreldin
Shmeylan Al Harbi
Abdullah Alhammad
Ramesh Vishwakarma
机构：
[1] King Abdulaziz University,Department of Pharmacy Practice, Faculty of Pharmacy
[2] King Abdulaziz Medical City,Pharmaceutical Care Department
[3] King Abdulaziz University,Department of Anesthesia and Intensive Care
[4] King Saud Bin Abdulaziz University for Health Sciences,College of Pharmacy
[5] King Abdullah International Medical Research Center,Pharmaceutical Care Department
[6] King Abdulaziz University Hospital,College of Pharmacy
[7] Princess Nourah Bint Abdulrahman University,Department of Clinical Pharmacy, College of Pharmacy
[8] King Saud University,College of Pharmacy
[9] University of Arizona,Department of Anesthesia and Intensive Care
[10] Brigham and Women’s Hospital,undefined
[11] Ain Shams University,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
COVID-19; SARS-Cov-2; Tocilizumab; Secondary infection; CRE; Critically ill; Intensive care units (ICUs); Immunomodulatory drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Alshabasy, Adel
    Eljaaly, Khalid
    Al Shaya, Abdulrahman I.
    Noureldeen, Haytham
    Aboudeif, Mohammed
    Al Dosari, Bodoor
    Alkhalaf, Amina
    Korayem, Ghazwa B.
    Aleissa, Muneera M.
    Badreldin, Hisham A.
    Al Harbi, Shmeylan
    Alhammad, Abdullah
    Vishwakarma, Ramesh
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [2] The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Korayem, Ghazwa B.
    Altebainawi, Ali F.
    Alsohimi, Samiah
    Alqahtani, Rahaf
    Alfaifi, Saeedah
    Alharbi, Aisha
    Alkhayrat, Azzah
    Hattan, Ahmed
    Albassam, Meshal
    Almohammed, Omar A.
    Alkeraidees, Atheer
    Alonazi, Dhay A.
    Alsalman, Weam F.
    Aldamegh, Ghaliah
    Alshahrani, Rasha
    Vishwakarma, Ramesh
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Efficacy of tocilizumab in critically ill COVID-19 patients: a retrospective cohort
    Sadaf, Sairah
    Bashir, Babar
    Haider, Syeda Sabahat
    Mustafa, Ghulam
    Naqvi, Syed Aushtar Abbas
    ANAESTHESIA PAIN & INTENSIVE CARE, 2021, 25 (03) : 295 - 302
  • [4] Baricitinib versus tocilizumab in critically ill COVID-19 patients: A retrospective cohort study
    Conroy, Grace M.
    Bauer, Seth R.
    Pallotta, Andrea M.
    Duggal, Abhijit
    Wang, Lu
    Sacha, Gretchen L.
    PHARMACOTHERAPY, 2024, 44 (01): : 28 - 38
  • [5] The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study
    Aljuhani, Ohoud
    Al Sulaiman, Khalid
    Korayem, Ghazwa
    Alharbi, Aisha
    Altebainawi, Ali F.
    Aldkheel, Shatha A.
    Alotaibi, Sarah G.
    Vishwakarma, Ramesh
    Alshareef, Hanan
    Alsohimi, Samiah
    AlFaifi, Mashael
    Al Shaya, Abdulrahman
    Alhaidal, Haifa A.
    Alsubaie, Raghad M.
    Alrashidi, Hessah
    Albarqi, Khalid J.
    Alangari, Dalal T.
    Alanazi, Reem M.
    Altaher, Noora M.
    Al-Dorzi, Hasan M.
    RENAL FAILURE, 2023, 45 (02)
  • [6] Tocilizumab: A retrospective multi-center cohort study of critically ill patients with COVID-19
    Santos, Claudia R. Villatoro
    Bhargava, Ashish
    Coyle, Meredith
    Szpunar, Susan
    Saravolatz, Louis D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (11) : 705 - 712
  • [7] The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
    Korayem, Ghazwa B.
    Aljuhani, Ohoud
    Altebainawi, Ali F.
    Al Shaya, Abdulrahman, I
    Alnajjar, Lina, I
    Alissa, Abdulrahman
    Aldhaeefi, Mohammed
    Kensara, Raed
    Al Muqati, Hessa
    Alhuwahmel, Abdulmohsen
    Alhuthaili, Omar
    Vishwakarma, Ramesh
    Aldardeer, Namareq
    Eljaaly, Khalid
    Alharbi, Aisha
    Al Harbi, Shmeylan
    Al Katheri, Abdulmalik
    Al Bekairy, Abdulkareem M.
    Aljedai, Ahmed
    Al Sulaiman, Khalid
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 252 - 259
  • [8] Association of BMI with Outcomes in Critically ill Patients with COVID-19: Multicenter Cohort Study
    Pattou, Francois
    Chetboun, Mikael
    Raverdy, Violeta
    Jourdain, Merce
    OBESITY, 2020, 28 : 8 - 8
  • [9] COVID-19 AND THE RISK OF INFECTIONS CAUSED BY MULTIDRUG-RESISTANT ORGANISMS: A RETROSPECTIVE COHORT STUDY IN A COMMUNITY HOSPITAL
    Meng, Qingqing
    Kishmiryan, Armen
    Egoryan, Goar
    Ramachandran, Akshaya
    Surbek, Stjepan
    Choi, Jaeyoun
    Begiashvili, Valiko
    Abu Nseir, Maria
    Rodriguez-Nava, Guillermo
    CHEST, 2023, 164 (04) : 798A - 798A
  • [10] Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study
    Huang, Edmund
    Isonaka, Sharon
    Yang, Haoshu
    Salce, Erin
    Rosales, Elisa
    Jordan, Stanley C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 245 - 251
12345